Meeting Modern Demands of Cleaning-in-Place Protocols
As downstream purification advances, the use of enhanced cleaning-in-place (CIP) protocols has expanded to maintain product integrity and ensure high-quality biopharmaceuticals.
Purolite DurA Cycle A50 is engineered to purify monoclonal antibodies (mAbs) and associated protein constructs under variable cleaning strategies.
Compared to standard affinity resins, Purolite DurA Cycle A50 offers mild pH elution, addressing aggregation and subsequent purity challenges.
Designed to reduce susceptibility to protein A leakage, Purolite DurA Cycle A50 offers an extended resin lifetime, lowering the cost per gram.
Purolite Chromatography Resins
Purolite DurA Cycle A50 is manufactured using patented Jetting technology, ensuring uniform particle size for enhanced quality and performance.
Jetting manufacturing supports sustainability through reduced use of harmful solvents and water usage. Compared to traditional methods, Jetting accelerates time to market with fewer production steps.